Cancer Research Institute

04/05/2026

CRI-funded scientists have been at the forefront of discovering how the immune system can be harnessed to fight multiple myeloma, from identifying new therapeutic targets and improving CAR T-cell therapies, to developing novel detection technologies and exploring how to prevent disease progression.

Today, CRI continues to invest in the next-generation of multiple myeloma immunotherapy research. Explore: https://bit.ly/3QbPKHy

Immunotherapy for Multiple Myeloma Learn how immunotherapy is transforming the treatment of multiple myeloma What Is Multiple Myeloma? Multiple myeloma is the second most common blood cancer worldwide, accounting for approximately 10% [...]

04/04/2026

Facing a stage 4 esophageal cancer diagnosis, Dana refused to accept the limits placed on her care. Fighting with uncertainty and discouraging odds, she pushed for answers when no clear path forward existed. Her persistence led her to an emerging immunotherapy treatment that changed everything. Hear more: https://bit.ly/3OdDDcB

Dana Deighton defied a stage 4 esophageal cancer diagnosis, advocating for herself and finding hope through immunotherapy.

04/03/2026

Congratulations to CRI Scientific Advisory Council Director Dr. James Allison, CRI SAC member Dr. Carl June, 2021 William B. Coley Award recipients and Nobel Prize laureates Dr. Katalin Karikó and Dr. Drew Weissman, and Nobel Prize laureates Dr. Fred Ramsdell and Dr. Jennifer Doudna, who have all been named to Forbes 250: America's Greatest Innovators.

"They aren’t just inventors; they’re business leaders who bring their breakthroughs to market, transforming entire industries and creating new ones." Discover:

The Forbes Innovator 250: America's Greatest Innovators showcases the visionaries shaping our future. Find the full list of great minds and the mark they are leaving on our history.

04/01/2026

At just 26, Mrinali Dhembla was diagnosed with stage 3 re**al cancer that had spread to her spine. Thanks to immunotherapy, she was declared cancer-free after only 4 months of treatment.

"Immunotherapy spared Dhembla from months of debilitating chemotherapy and radiation treatments, and Dhembla even ran a 5K during her treatment period," ABC News describes. Hear more: https://bit.ly/4c2ch11

A 26-year-old is now "cancer-free" after receiving a new treatment for colore**al cancer.

03/31/2026

🫂 1 in 5 people diagnosed with colore**al cancer are under age 55. During March's Colore**al Cancer Awareness Month, discover potential risk factors, and review prevention tips, with NBC Bay Area and CRI:

Medical experts are reminding young adults to be screened early for colore**al cancer due to an increase in cases for people under the age of 55.

03/30/2026

📊 While melanoma and lung cancer have seen dramatic survival gains, many cancers remain resistant to current immunotherapies. The 5 year survival rate for pancreatic cancer remains at just 13%, and uterine corpus cancer mortality has risen for 26 consecutive years.

↪️ Discover what lies ahead for immunotherapy, and explore what can be done to continue to unlock its potential for all patients: https://bit.ly/3OxCNam

03/29/2026

Gordon had exhausted nearly every treatment option to fight stage 4 colore**al cancer. Discover how a second opinion and a new immunotherapy combination changed everything: https://bit.ly/403f3gW

After exhausting nearly every option for stage 4 colore**al cancer, Gordon Levine found new hope in immunotherapy. Today, he's cancer-free and advocating for more patients to get the same second chance.

03/28/2026

How does immunotherapy differ from chemotherapy? Is immunotherapy right for everyone with kidney cancer? Get answers to your most frequently asked immunotherapy questions, during March's Kidney Cancer Awareness Month: https://bit.ly/4aYovZd

Learn about kidney cancer during Kidney Cancer Awareness Month, including how immunotherapy is transforming treatment options and ongoing research.

03/27/2026

🌟 In the US, the 5 year relative survival rate for all cancers has reached a historic milestone of 70% during 2015–2021, up from 49% in the mid-1970s. Most striking are the dramatic gains in survival for advanced, metastatic cancers that were often considered untreatable just a generation ago.

✏️ Learn how immunotherapy is reshaping the odds for patients, and discover what barriers continue to block the road ahead: https://bit.ly/3OxCNam

03/26/2026

What’s the difference between colon cancer and re**al cancer? Does immunotherapy work for everyone with colore**al cancer?

Get answers to your most frequently asked questions regarding colore**al cancer and immunotherapy, during March's Colore**al Cancer Awareness Month, in A Patient’s Guide to Cancer Immunotherapy: Colore**al Cancer. Discover: https://bit.ly/4sLx2EO

A Patient's Guide to Cancer Immunotherapy Colore**al Cancer What You Need to Know Hearing the words “You have colore**al cancer” can feel overwhelming. You may feel scared, confused, or uncertain about what [...]

03/25/2026

When Peggy was diagnosed with stage 4 kidney cancer, she refused to let confusion and silence define her experience. After immunotherapy eliminated her tumors, she found a new purpose: helping other patients understand their disease and speak up for themselves. More: https://bit.ly/3P14ysf

After a stage 4 kidney cancer diagnosis, immunotherapy put Peggy Zuckerman into lasting remission. Today, she helps patients find clarity and confidence.

03/24/2026

"We’ve come a long way in cancer treatment. I don’t use the word “cure” lightly, but that’s what we’re reaching for," says CRI's CEO, Dr. Alicia Zhou. "Immunotherapy is one of the few areas where we can actually say it: there are patients with stage 4 cancer who were treated with immunotherapy and are now disease-free. Immunotherapy lets us dream bolder about what’s possible in cancer treatment."

Read more: https://bit.ly/3NI72vh

An Interview With Dr. Sonya Reddy